Varisella Zoster Virusun Santral Sinir Sistemi Üzerine Etkileri

Whitley RJ. Chickenpox and Herpes zoster (Varicella-Zoster Virus) In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th ed. Philedelphia, 2020:1849-1855.

Arnold N, Messaoudi I. Herpes zoster and the search for an effective vaccine. Clin Exp Immunol. 2017;187(1):82-92. doi: 10.1111/cei.12809.

Gershon AA, Breuer J, Cohen JI, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015:1:15016. doi: 10.1038/nrdp.2015.16.

Cohen JI. Clinical practice: Herpes zoster. N Engl J Med. 2013;369(3): 255–263. doi: 10.1056/NEJMcp1302674.

Gnann JW. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis. 2002:S91-8. doi: 10.1086/342963.

Giannelos N, Curran D, Nguyen C, et al. The Incidence of Herpes Zoster Complications: A Systematic Literature Review. Infect Dis Ther. 2024;13(7):1461-1486. doi: 10.1007/s40121-024-01002-4.

7. Nagel MA, Gilden D. Complications of varicella zoster virus reactivation. Curr Treat Options Neurol. 2013;15:439-453. doi: 10.1007/s11940-013-0246-5.

Watson CP, Watt VR, Chipman M, et al. The prognosis with postherpetic neuralgia. Pain. 1991;46:195-199. doi: 10.1016/0304 3959(91)90076-A.

Lai J, Porreca F, Hunter JC, et al. Voltage-gated sodium channels and hyperalgesia. Annu Rev Pharmacol Toxicol. 2004;44, 371–397. doi: 10.1146/annurev.pharmtox.44.101802.121627.

Kennedy PGE, Montague P, Scott F, et al. Varicella-Zoster viruses associated with post-herpetic neuralgia induce sodium current density increases in the ND7-23 Nav-1.8 neuroblastoma cell line. PLos One. 2013;8(1):e51570. doi: 10.1371/journal.pone.0051570.

Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl. J. Med. 2005;352, 2271–2284. doi: 10.1056/NEJMoa051016.

Cunningham AL, Lal H, Kovac M, et al. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. N. Engl. J. Med. 2016;375:1019–1032. doi: 10.1056/NEJMoa1603800

Lin HC, Chien CW, Ho JD. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology. 2010;74:792–797. doi: 10.1212/WNL.0b013e3181d31e5c.

Grose C. Stroke after varicella and zoster ophthalmicus: another indication for treatment and immunization. Pediatr. Infect. Dis. J. 2010;29(9):868–869. doi: 10.1097/INF.0b013e3181ddef9e.

Lefond CA, bernard TJ, Sebire G, et al. Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study. Circulation. 2009;119:1417–23. doi: 10.1161/CIRCULATIONAHA.108.806307.

Nagel MA, Jones D, Wyborny A, et al. Varicella zoster virus vasculopathy: The expanding clinical spectrum and pathogenesis. J Neuroimmunol. 2017:308:112-117. doi: 10.1016/j.jneuroim.2017.03.014.

Eleftheriou D, Moraitis E, Hong Y, et al. Microparticle-mediated VZV propagation and endothelial activation: Mechanism of VZV vasculopathy. Neurology. 2020;94:e474-e480. doi: 10.1212/WNL.0000000000008885.

Nagel MA, Cohrs RJ, Mahalingam R, et al. The varicella zoster virüs vasculopathies: clinical, CSF, imaging, and virologic features. Neurology. 2008;70(11):853-60. doi: 10.1212/01.wnl.0000304747.38502.e8.

Lu P, Cui L, Zhang X. Stroke risk after varicella zoster virus infection: a systemic review and meta-analysis. J Neurovirol. 2023;29(4):449-459. doi: 10.1007/s13365-023-01144-0.

Klaric JS, Beltran TA, McClenathan BM. An Association Between Herpes Zoster Vaccination and Stroke Reduction Among Elderly Individuals. Mil Med. 2019;184 (Suppl 1):126-132. doi: 10.1093/milmed/usy343.

Gilden D, White T, Khmeleva N, et al. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology. 2105;84:1948–1955. doi: 10.1212/WNL.0000000000001409.

Verdijk RM, Ouwendijk WJD, Kuijpers RWAM, et al. No Evidence of Varicella-Zoster Virus Infection in Temporal Artery Biopsies of Anterior Ischemic Optic Neuropathy Patients With and Without Giant Cell Arteritis. J Infect Dis. 2021;223(1):109-112. doi: 10.1093/infdis/jiaa566.

Dulin M, Chevret S, Salmona M, et al. New Insights Into the Therapeutic Management of Varicella Zoster Virus Meningitis: A Series of 123 Polymerase Chain Reaction–Confirmed Cases. Open Forum Infect Dis. 2024;11(7):ofae340. doi: 10.1093/ofid/ofae340.

Lewis GW. Zoster sine herpete. Br Med. 1958;J2:418–42. doi: 10.1136/bmj.2.5093.418.

Franco-Paredes C, Bellehemeur T, Merchant A, et al. Aseptic meningitis and optic neuritis preceding varicella-zoster progressive outer retinal necrosis in a patient with AIDS. AIDS. 2002;16,1045–1049. doi: 10.1097/00002030-200205030-00011.

Moorthy RS, Weinberg DV, Teich SA, et al. Management of varicella zoster virus retinitis in AIDS. Br J Ophthalmol. 1997;81:189–94. doi:10.1136/bjo.81.3.189

Sotelo J, Corona T. Varicella zoster virus and relapsing remitting multiple sclerosis. Mult Scler Int. 2011;2011:214763. doi:10.1155/2011/214763.

Kang JH, Sheu JJ, Kao S, et al. Increased risk of multipl sclerosis following herpes zoster. J Infect Dis. 2011;204(2):188-192. doi: 10.1093/infdis/jir239.

Grahn A, Nilsson S, Nordlund A, et al. Cognitive impariment 3 years after neurological varicella-zoster virus infection: a long term case control study. J Neurol. 2013;260(11):2761-2769. doi: 10.1007/s00415-013-7057-1.

Yeh TS, Curhan GC, Yawn BP, et al. Herpes zoster and long-term risk of subjective cognitive decline. Alzheimer's Research & Therapy. 2024:180. doi:10.1186/s13195-024-01511-x.

Gash CW, Forbes HJ, Williamson E, et al. Human herpesvirus infections and dementia or mild cognitive impairment: a systemic review and meta-analysis. Sci Rep. 2019;9(1):4743. doi: 10.1038/s41598-019-41218-w.

Schmidt SAJ, Veres K, Sorensen HT, et al. Incident herpes zoster and risk of dementia: A population-based Danish cohort study. Neurology. 2022;99(7):e660-e668. doi: 10.1212/WNL.0000000000200709.

Chen VCH, Wu SI, Huang KY, et al. Herpes zoster and dementia: an nationwide population –based cohort study. J Clin Psychiatry. 2018;79(1):16m11312. doi: 10.4088/JCP.16m11312.

Thapa S, Shah S, Bhattarai A, et al. Risk of dementia following herpes zoster infection among patients undertreatment versus those not: A systematic review and meta-analysis. Health Sci Rep. 2024;7(3):e1941. doi: 10.1002/hsr2.1941.

Cairns DM, Itzhaki RF, Kaplan DL. Potential involvement of varicella zoster virus in Alzheimer’s disease via reactivation of quiescent herpes simplex virus type 1. J Alzheimers Dis. 2022;88(3):1189-1200. doi: 10.3233/JAD-220287.

Zhang Y, Liu W, Xu Y. Association between herpes zoster and Parkinson’s disease and dementia: a systematic review and meta-analysis. Front Neurol. 2024 Dec 5:15:1471736. doi: 10.3389/fneur.2024.1471736.

Shah S, Dahal K, Thapa S, et al. Herpes zoster vaccination and the risk of dementia: A systematic review and meta‐analysis. Brain Behav. 2024;14(2):e3415. doi: 10.1002/brb3.3415

Taquet M, Dercon Q, Todd JA, et al. The recombinant shingles vaccine is associated with lower risk of dementia. Nat Med. 2024;30(10):2777-2781. doi: 10.1038/s41591-024-03201-5.

Eyting M, Xie M, Michalik F, et al. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. 2025;641(8062):438-446. doi: 10.1038/s41586-025-08800-x.